Larvol Delta - An-Openlabel-Singlearm-Multicenter-Phase-II-Clinical-Study-of-Azacitidine-Chidamide-Combined-With-PD1-Monoclonal-Antibody-in-the-Treatment-of-RefractoryRelapsed-Peripheral-Tcell-Lymphoma

Epidaza (chidamide) - Chipscreen

Rituxan (rituximab) - Roche

lisaftoclax (APG-2575) - Ascentage Pharma

http://clinicaltrials.gov/ct2/show/NCT07601607

May 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next